Embolization Particles Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2018 - 2026


Transparency Market Research

$ 5795

The global embolization particles market can be segmented based on product, application, end-user, and region. Based on product, the market can be classified into radioembolization spheres, microspheres, drug eluting beads, and other particles. The embolization particles market is expected to expand at a rapid pace during the forecast period. Embolization particles are highly utilized in the treatment of cancer, whose prevalence has been increasing across the globe.

In terms of application, the global embolization particles market can be categorized into peripheral vascular disease, neurology, oncology, urology, and others. The peripheral vascular disease segment dominates the market. However, increase in prevalence of cancer globally has led to robust expansion of the oncology segment, which is expected to record high growth during the forecast period. According to Globocan, the incidence of liver cancer was 5.6% of the total cancer incidence in 2012; breast cancer was 11.9%, stomach cancer was 6.8%, and colorectal cancer was 9.7%. Embolization particles are the primary products used in the treatment of malignancies. Increase in awareness about uterine fibroid embolization procedures (UFE) and benign prostatic hyperplasia treatment through embolization is expected to boost the market in the next few years.

Based on end-user, the global embolization particle market can be divided into hospitals, ambulatory centers, and clinics. The hospitals segment constituted a major market share and is likely to maintain its leading position during the forecast period. A large part of the population prefers visiting hospitals first rather than ambulatory surgical centers or clinics for embolization procedures. Hospitals are the most favored setting for embolization procedures. However, the number of ambulatory surgical centers is increasing, specifically in emerging markets, as they provide embolization treatments at lower costs than hospitals.

In terms of region, the embolization particle market can be divided into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America accounted for a prominent share of the embolization particle market due to the presence of major market players in the region. Most of the key players operating in the region have made a series of strategic acquisitions, which have contributed to the increase in their market share. Increase in cancer prevalence in the region is the one of the key factors contributing to the expansion of the market. According to the American Cancer Society, over 1,658,370 new cancer cases were diagnosed and 589,430 cancer deaths reported in the U.S. in 2015. Well-established reimbursement policies by private and public organizations is a major factor boosting the adoption of these devices in the region.

Europe is a prominent region of the embolization particle market due to increase in adoption of minimally invasive procedures for treatment. Embolization procedures have fewer side effects due to their minimally invasive nature and faster wound healing process. Rise in awareness among patients regarding embolization procedures and their associated benefits such as short hospital stay and fast healing process also contributes to market growth. Technological innovations and significant product launches also drive the market in the region. The market in Asia Pacific and Latin America is expected to expand at a rapid pace during the forecast period. Increased focus by federal governments on enhancing health care facilities, and booming medical tourism, are factors propelling the market in these regions.

Major players operating in the embolization particle market are Abbott Laboratories, Boston Scientific Corporation, BTG plc, Cook Medical, Inc., Edwards Lifesciences, Johnson & Johnson, Pfizer, Inc., Sirtex Medical Limited, St. Jude Medical, Inc., and Terumo Corporation. The market is characterized by significant acquisitions, which has led to consolidation, increasing the dominance of a few top players.

MRR.BIZ has been compiled in-depth market research data in the report after exhaustive primary and secondary research. Our team of able, experienced in-house analysts has collated the information through personal interviews and study of industry databases, journals, and reputable paid sources.

The report provides the following information:

  • Tailwinds and headwinds molding the market’s trajectory
  • Market segments based on products, technology, and applications
  • Prospects of each segment
  • Overall current and possible future size of the market
  • Growth pace of the market
  • Competitive landscape and key players’ strategies

The main aim of the report is to:

  • Enable key stakeholder’s in the market bet right on it
  • Understand the opportunities and pitfalls awaiting them
  • Assess the overall growth scope in the near term
  • Strategize effectively with respect to production and distribution

MRR.BIZ is a leading provider of strategic market research. Our vast repository consists research reports, data books, company profiles, and regional market data sheets. We regularly update the data and analysis of a wide-ranging products and services around the world. As readers, you will have access to the latest information on almost 300 industries and their sub-segments. Both large Fortune 500 companies and SMEs have found those useful. This is because we customize our offerings keeping in mind the specific requirements of our clients.